| RS2105619771 |
SCN3A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 62 |
| RS2105620059 |
SLC40A1
|
Health Risk |
Likely pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS2105620090 |
SLC40A1
|
Health Risk |
Likely pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS2105621335 |
SCN3A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 62 |
| RS2105621618 |
SCN3A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 62 |
| RS2105621916 |
SLC40A1
|
Health Risk |
Likely pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS2105622062 |
SLC40A1
|
Health Risk |
Likely pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS2105622677 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2105625178 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2105627349 |
MBD5
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2105627859 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS2105628182 |
SLC40A1
|
Health Risk |
Likely pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS2105628869 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105629680 |
LNPK
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum, Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum |
| RS2105630210 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2105630442 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105631709 |
SLC40A1
|
Health Risk |
Likely pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS2105632746 |
COL5A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2105633124 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2105633619 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2105635449 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2105635851 |
SCN3A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 62 |
| RS2105636234 |
SCN3A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 62 |
| RS2105636283 |
SCN3A
|
Health Risk |
Likely pathogenic |
— |
| RS2105639771 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2105642195 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2105652981 |
COL5A2
|
Health Risk |
Likely pathogenic |
— |
| RS2105672766 |
EXOC6B
|
Health Risk |
Likely pathogenic |
— |
| RS2105675391 |
AGPS
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 3, Rhizomelic chondrodysplasia punctata type 3 |
| RS2105685436 |
EXOC6B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2105686869 |
COL5A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2105686874 |
COL5A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2105689812 |
DYNC1I2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly and structural brain anomalies, Neurodevelopmental disorder with microcephaly and structural brain anomalies |
| RS2105693633 |
AGPS
|
Health Risk |
Likely pathogenic |
— |
| RS2105706426 |
SATB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Chromosome 2q32-q33 deletion syndrome, Inborn genetic diseases |
| RS2105706833 |
DCAF17
|
Health Risk |
Pathogenic |
Woodhouse-Sakati syndrome, Woodhouse-Sakati syndrome |
| RS2105707111 |
SATB2
|
Health Risk |
Pathogenic |
Cerebellar ataxia, Cerebellar ataxia |
| RS2105711729 |
BMPR2
|
Health Risk |
Likely pathogenic |
Pulmonary venoocclusive disease 1, Pulmonary venoocclusive disease 1 |
| RS2105712248 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Pulmonary arterial hypertension |
| RS2105712267 |
BMPR2
|
Health Risk |
Likely pathogenic |
Pulmonary hypertension, primary |
| RS2105712615 |
COL5A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2105727398 |
PDE11A
|
Health Risk |
Likely pathogenic |
Pigmented nodular adrenocortical disease, primary |
| RS2105754294 |
ICOS
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS2105763978 |
SCN3A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2105768966 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS2105769270 |
SATB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS2105772518 |
SCN3A
|
Health Risk |
Likely pathogenic |
— |
| RS2105772689 |
SCN3A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 62 |
| RS2105772857 |
CTLA4
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency |
| RS2105776898 |
SCN3A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 62 |
| RS2105784954 |
EEF1B2
|
Health Risk |
Pathogenic |
Global developmental delay, Global developmental delay |
| RS2105787237 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS2105789154 |
SATB2
|
Health Risk |
Likely pathogenic |
— |
| RS2105792738 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2105793066 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105793178 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105793286 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105793395 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105794174 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105794473 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105794716 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105795469 |
SATB2
|
Health Risk |
Likely pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS2105795792 |
GAD1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 89, Developmental and epileptic encephalopathy 89 |
| RS2105795955 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105796316 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS2105796481 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS2105796501 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS2105797148 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS2105797158 |
CERKL
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 26, Cone-rod dystrophy |
| RS2105797652 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS2105797671 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105797686 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105801986 |
GAD1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 89, Developmental and epileptic encephalopathy 89 |
| RS2105803582 |
CERKL
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 26, Retinitis pigmentosa 26 |
| RS2105803798 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS2105804184 |
CERKL
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 26, Retinitis pigmentosa 26 |
| RS2105805349 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105805625 |
CERKL
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 26, Retinitis pigmentosa 26 |
| RS2105805638 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105805670 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS2105805934 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105806061 |
C2CD6
|
Health Risk |
Pathogenic |
Spermatogenic failure 68, Spermatogenic failure 68 |
| RS2105806212 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105806338 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Developmental and epileptic encephalopathy 6B |
| RS2105806431 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105806501 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS2105807030 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105807206 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105807547 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105807979 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105808409 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105808458 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105808640 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS2105808820 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105808860 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2105808993 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105816922 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105816934 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2105817051 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105817065 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Inborn genetic diseases |